Total submissions: 16
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Clin |
RCV005053886 | SCV005687735 | benign | GUCY2D-related recessive retinopathy | 2025-01-30 | reviewed by expert panel | curation | The NM_000180.4(GUCY2D):c.154G>T (p.Ala52Ser) variant is predicted to replace the alanine at position p.52 with serine. This variant is present in gnomAD v.4.1.0 at a GrpMax allele frequency of 0.6857, with 26306 alleles / 37974 total alleles in the East Asian population, which is higher than the ClinGen LCA / eoRD VCEP BA1 threshold of >0.016 (BA1). This variant has been found in the homozygous state in 95,479 adult individuals in gnomAD v4.1.0 (BS2). The computational predictor REVEL gives a score of 0.126, which is below the ClinGen LCA / eoRD VCEP threshold of ≤0.183 and predicts a non-damaging effect on RetGC-1 protein function. In addition, the splicing impact predictor SpliceAI gives a delta score of 0.0, which is below the ClinGen LCA / eoRD VCEP recommended threshold of <0.1 and does not predict an impact on splicing (BP4_Moderate). In summary, this variant meets the criteria to be classified as Benign for GUCY2D-related recessive retinopathy based on the ACMG/AMP criteria applied, as specified by the ClinGen LCA/eoRD VCEP: BA1, BS2, BP4_Moderate. (VCEP specifications version 1.0.0; date of approval 01/22/2025). |
Eurofins Ntd Llc |
RCV000078318 | SCV000110164 | benign | not specified | 2016-03-16 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV000078318 | SCV000302884 | benign | not specified | criteria provided, single submitter | clinical testing | ||
Labcorp Genetics |
RCV001518075 | SCV001726709 | benign | Cone-rod dystrophy 6; Leber congenital amaurosis 1 | 2025-02-03 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000084835 | SCV001751694 | benign | not provided | 2015-03-03 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV000084835 | SCV002049064 | benign | not provided | 2023-11-29 | criteria provided, single submitter | clinical testing | |
Molecular Genetics, |
RCV002225071 | SCV002503738 | benign | Cone-rod dystrophy 6 | 2021-10-04 | criteria provided, single submitter | clinical testing | Population allele frequency is 40% (rs61749665, 54,832/138,790 alleles in gnomAD v2.0.2). Based on the classification scheme RMH ACMG Guidelines v1.1.1, this variant is classified as Benign. Following criteria met: BA1 |
Fulgent Genetics, |
RCV002490349 | SCV002802295 | benign | Choroidal dystrophy, central areolar, 1; Cone-rod dystrophy 6; Leber congenital amaurosis 1; Night blindness, congenital stationary, type1i | 2021-09-01 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV000084835 | SCV005251556 | benign | not provided | criteria provided, single submitter | not provided | ||
OMIM | RCV000009947 | SCV000030168 | pathogenic | Leber congenital amaurosis 1 | 1998-08-01 | flagged submission | literature only | |
Retina International | RCV000084835 | SCV000116971 | not provided | not provided | no assertion provided | not provided | ||
Department of Ophthalmology and Visual Sciences Kyoto University | RCV000084835 | SCV000172504 | probable-non-pathogenic | not provided | no assertion criteria provided | not provided | Converted during submission to Likely benign. | |
Diagnostic Laboratory, |
RCV000078318 | SCV001740881 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics, |
RCV000078318 | SCV001921526 | benign | not specified | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV000078318 | SCV001956221 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000078318 | SCV001972869 | benign | not specified | no assertion criteria provided | clinical testing |